Strategic investment from Oak HC/FT and Cedars-Sinai Health Ventures will support the rapid expansion of Regard’s AI-powered clinical insights platform aimed at unlocking the full power of the EHR
Regard, the AI-powered clinical insights platform that empowers clinicians to unlock the full potential of patient data, announced the close of a $61 million Series B financing round, led by Oak HC/FT, with participation from Cedars-Sinai Health Ventures, as well as existing investors TenOneTen Ventures, Calibrate Ventures, and Techstars. The investment will enable the company to accelerate product development with their core clinical insights platform, invest in fundamental research in large language models (LLMs) and expand beyond inpatient facilities.
“Regard is positioned to revolutionize how we think about clinical decision-making support for doctors,” said Nancy Brown, General Partner at Oak HC/FT. “The team at Regard has built a platform that is driving value for patients, physicians and health systems alike by improving outcomes, increasing efficiency, reducing burnout, and increasing revenue. Eli and Nate have been thoughtful about product development and we are thrilled to be a part of this next chapter where they look to deliver this value at scale.”
An influx of new technologies has generated more healthcare data than ever, yet much of it remains untapped for clinical care. According to The World Economic Forum, less than 3% of available patient data is used by a physician. With an average of 50,000 data points per patient, the gap between the vast amount of data available and clinically actionable insights generated from it is significant. Regard bridges the clinical insights gap by analyzing all available data and recommending diagnoses, enabling clinicians to deliver better care. Once recommendations are reviewed and approved by the clinician, Regard ensures complete and accurate documentation in a standardized format, a critical step to ensure clinical quality and enhance hospital revenue.
Also Read: Call Box Launches AI Mystery Shop Scorecard and AI-Powered Call Transcriptions and Recaps to Elevate Healthcare Communication
“Cedars-Sinai has been working alongside Regard from the early days of the business because we saw a real need to empower physicians with the data that can provide critical analysis and insights to assist in diagnosis and treatment,” said Maureen Burgess, Partner at Cedars-Sinai Health Ventures. “And, even more importantly, we believe it will improve patient care as well as the patient experience.”
Since its launch in 2021, Regard’s technology has surfaced more than three million diagnoses to care teams and generated more than $50 million in incremental revenue for enterprise health system partners including Banner Health and Sentara. Most recently, the company announced a partnership with WakeMed Health & Hospitals, a leading health system in Raleigh, North Carolina.
“Imagine a doctor having all the EHR information they need about a patient, right in front of them, in just seconds. Regard is augmenting patient care by analyzing overwhelming mountains of clinical data and providing clinicians with potential diagnoses and treatment recommendations, impacting the quality and safety of care in real-time,” said Eli Ben-Joseph, CEO at Regard. “That’s a game-changer – not just for doctors, but for the people whose lives are in their hands.”
Source: PRNewswire